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Available online 28 August 2012 With increasingly stringent regulations regarding deferral and elimination of blood donors
it will become increasingly important to extend the expiration date of blood components
beyond the current allowed storage periods. One reason for the storage time limit for blood
components is that platelets and red blood cells develop a condition called storage lesions
during their storage in plastic blood containers. Systems biology provides comprehensive
bio‐chemical descriptions of organisms through quantitative measurements and data
integration in mathematical models. The biological knowledge for a target organism can be
translated in a mathematical format and used to compute physiological properties. The use
of systems biology represents a concrete solution in the study of blood cell storage lesions,
and it may open up new avenues towards developing better storage methods and better
storage media, thereby extending the storage period of blood components.
This article is part of a Special Issue entitled: Integrated omics.




Red blood cell storage lesions
1. Introduction
Since the time of the ancient Greeks, blood has been revered for
its healing and regenerative power, so much so that bathing in
blood and ingesting it were considered a remedy well into the
middle ages [1]. Blood has two abundant cell types, red blood
cell (RBC) and platelet (PLT). RBC has the physiological role of
transporting oxygen from the lungs to the tissues and carbon
dioxide back to the lungs, while PLT participates in homeostasis
by forming blood clots and serving as a reservoir of different
cytokines and growth factors.
Modern medicine is greatly dependent on the banking and
transfusion of blood products for use as support treatments
during cancer therapies, for trauma and burn treatments,
obstetrics, and various surgeries. Blood components used in
these treatments are derived and processed from volunteer
blood donors that have undergone a strict screening process.
Amajor problem that blood banks will face in the near future
is a steady decline in the number of qualified blood donors [2].
With increasingly stringent regulations regarding deferral and
eliminationof blooddonors itwill become increasingly important
to extend the expiration date of blood components beyond the
current allowed storage periods. Currently, the storage period
ranges from 35 to 42 days (at 2–6 °C) for RBC concentrates and
5–7 days (22 °C with agitation) for PLT concentrates [3]. One
reason for the storage time limit for blood components is that PLT
and RBC develop a condition called storage lesions during their
storage in plastic blood containers.
Red blood cell storage lesion (RSL) has various effects on
the RBC, including changes in the metabolic status of the cell
that include a breakdown of metabolic sugars to lactate and
protons via glycolysis which subsequently result in a lower pH
and a loss of 2,3-diphospholgycerate (2,3-DPG). The loss of
2,3-DPG coincides with a shape change and a membrane loss
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in the RBC due to oxidation of proteins and lipids that leads to
a breakdown of the RBC and their failure to survive once they
return to circulation [3]. RSL can also lead to secondary risks
that include an accumulation of potassium in the RBC unit
that can increase the risk of arrhythmias upon transfusion.
Platelet storage lesion (PSL) leads to a significant loss of
platelet function during 5 days of storage. This lesion causes
changes in platelet morphology, physiological activation with
subsequent exposure of membrane phosphatidylserine and
release of platelet granules. As consequence of these changes,
platelets lose the ability to aggregate and show reduction of
matrix adhesion properties. Changes in cell metabolism are also
observed. In fact platelets seem to experience anaerobic glycol-
ysis resulting in accumulation of lactic acid and decrease in pH,
leading to decline in mitochondrial activity and subsequent
apoptosis [4].
While the underlying mechanisms of RSL and PSL are far
from being fully understood, it is clear that they are caused by
a multitude of different components. Development of RSL and
PSL is usually related to collection methods, storage methods,
and post collection manipulation including storage solutions.
A full understanding of storage lesions in red blood cells and
platelet is needed in order to figure out ways to extend the
storage period of blood components. Current methods that
are used to detect storage lesions have their limitations, and
therefore new tools are needed in order to decipher the
storage lesion of RBC and PLT.
Integrated omics has been an overlooked concept in transfu-
sion medicine and storage of transfusion products. This special
issue offers a glimpse into what is happening in this field, and it
provides evidence supporting the important role that integrated
omics platforms can play in the study of blood cells.
For instance, an integrated omics strategy was used by
Thiele et al. to map out the molecular pathways involved in
PSL, describing integrin αIIbβ3 and focal adhesion signaling
pathways as key players in irreversible PSL and subsets of PLT
mRNA that may be important in early PSL formation [5].
Antonelou et al. address the subject of pre-storage leuko-
reduction of RBC concentrates with focus on senescence and
oxidative stress associated with molecular and cellular modifi-
cations. Their data indicates that residual leukocytes and
platelets that are present in non-leukoreduced RBC concentrates
may impose an additional stress on the RBC affecting most RBC
removal signaling and thereby their structural and functional
integrity [6].
Delobel et al. focused on carbonylation that is believed to
be a pinnacle part of oxidative stress of RBC during the
storage. Their conclusion is that carbonylation of cytoplasmic
and membrane proteins differs during the storage period,
describing two spate steps in the evolution of carbonylation
during RBC concentrate storage [7].
Vesiculation from RBC is believed to prevent untimely
removal of RBC from the circulation by removing damaged
membrane parts from the RBC, that are enriched with
removal signals such as phosphatidylserine and IgG [8].
Bosman et al. mention the generation of vesicles during
blood bank storage [9]. Proteomics analysis focused on the
aging and vesiculation of RBC in vivo may point out solutions
to prevent or reduce the formation of vesiculation of RBC
during blood banking.
This issue is also presenting alternative approaches to
ensure more efficient and safer products in transfusion
medicine, as reported by Schubert et al., which suggest the
use of integrated omics as a tool to predict transfusion
outcome and improve donor management, proposing RRap1
and RhoGDI as valuable markers in this context [10].
The increasing use of integrated omics approaches for the
study of blood cell storage lesions may be the prelude to
integrated systems biology platforms achieved by integration
of omics data in mathematical models.
2. Systems biology
Systems biology is suddenly everywhere. Its community in-
cludes researchers worldwide, spanning disciplines from met-
abolic engineering to life sciences. In classical biology, the
reductionist approach has been pervasive over the last century.
It considers a complex system as the sum of its parts that are
described with a hierarchy of organizations. This approach has
been successfully used in biology to identify its molecular
components and, in part, their biological functions. Unfortu-
nately, it falls short when considering the nature of the links
between components and the network resulting from the
assembly of all such links.
Systems biology is about putting together rather than
taking apart, and it provides comprehensive biochemical
descriptions of organisms through quantitative measure-
ments and data integration in mathematical models. The
driving force for this emerging field has been the development
of high-throughput technologies that generate the so-called
omic data sets. In fact, in the last decade, multi-omics high-
density data sets have been generated, providing extensive
knowledge of the biological components while raising the
issue of data curation and integration at the same time.
The biological knowledge for a target organism can be
translated in a mathematical format and used to compute
physiological properties. This translation results in a genome
scale metabolic reconstruction, which represents a biochem-
ical, genetic and genomic (BIGG) knowledge base [11] for a
target organism. These reconstructions may then be used to
investigate fundamental biological questions, guide industrial
strain design, and provide a systems perspective for analysis
of the expanding ocean of omics data [12–14].
In 2007 the first genome scale metabolic reconstruction of
Homo sapiens (Recon 1) was presented [15]. Recon 1 represent-
ed the comprehensive knowledge of human metabolism and
suddenly it was realized that it could be used as a starting
point for generating tissue and condition-specific models by
integrating omics data. In fact, metabolomics, proteomics,
and transcriptomics data obtained from a particular tissue or
cell line in defined conditions can be used to generate a model
which is not only specific for the tissue but for the conditions
investigated as well. The procedure to obtain such a recon-
struction is well defined and partially automated [16], leading
to an exponential increase in the number of reconstructions
and in silico modeling strategies [17,18].
Data integration with mathematical models and the
capability to generate multi-omic datasets are now leading
to a new approach where the generation and integration of
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data are part of a new platform for integrated systems biology.
The fast development of such a platform is desirable and
necessary in systems biology and requires multi-disciplinary
input from an array of biological, computational, analytical,
and clinical experience.
3. Systems biology of stored blood cells
Red blood cells and platelets are enucleated cells with
relatively simple metabolism, whose biochemistry and phys-
iology are very well studied. In fact, the first mathematical
model of erythrocytes was presented in 1974 and it included
only the glycolysis [19]. In the last 10 years, the consolidation
of well defined analytical platforms for proteomics has led to
an increased number of studies focused on the proteome of
platelets and red blood cells, describing cells that are meta-
bolically more active than previously thought.
In 2011, Bordbar et al. used the available proteomics data to
reconstruct themost expansive description of RBCmetabolism to
date, and used it to simulate its physiological and patho-
physiological states. Using in silico simulations, the study
showed that RBCs can be used as a diagnostic for drug treated
conditions [20]. In a previous study, Nishino et al. developed a
mathematical model for erythrocytes and used it to predict
metabolic changes occurring during their long-term storage. In
silico simulations reproduced the reported time-courses of ATP
and 2.3-DPG during storage and these predictions were validated
by comparison with metabolomics data [21].
While several proteomics studies have also been reported for
the study of storage lesions of both platelets and red blood cells,
there is a lack ofmetabolomics studies on this topic to date. Gevi
et al. reported a study in which intra- and extra-cellular
metabolites of red blood cells were profiled during cold storage.
During storage, a continuous exchange of metabolites occurs
between the extracellular and intracellular environments, as cells
take up nutrients and excrete metabolites. By monitoring the
exchange of metabolites between the intracellular and extracel-
lular environments and the intracellular metabolites over time,
theauthorswereable toprovideamoredetailedpictureof the red
blood cell metabolism [22]. They confirmed the rapid fall of
glycolysis rate and the accumulation of glycolysis end products
together with purine salvage pathway products. Moreover they
highlighted the role of oxidative stress during the storage. In a
successive study, D'Alessandro et al. have used an integrated
metabolomics and proteomics approach for a time course
investigation on stored RBC, pointing out that most of the
biochemical and structural changes associated with the RSL
occur after 2 weeks of storage [23].
The increasing availability of omics data for stored blood
cells will lead to the development of integrated systems
biology platforms. Nevertheless to reach this objective it is
necessary to develop and refine procedures, on the computa-
tional and experimental sides.
This synergy between experimental and computational
sciences may provide further insight into the molecular
mechanism of RSL and PSL.
Here, a pipeline for the use of in silico strategies in the
study of the blood cell storage lesions is suggested (Fig. 1).
i. Step 1: Context-specific metabolic reconstruction.
The first step consists in generating a cell specific
metabolic reconstruction. A global human network
reconstruction (Recon 1) has served as an effective
starting point to develop tissue specific models. Further
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Fig. 1 – Systems biology pipeline to study stored blood cells.
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condition specific tailoring of the metabolic network
through integration of context-specific omics data by
using various algorithmic approaches [24–27].
Regardless of the method however, in order to generate
high quality models, some steps will require manual
curation and in-depth literature search to ensure high
quality and coverage of the reconstruction.
Quantitative omics data focusing on blood cell storage
lesions are required in order to achieve these objectives.
ii. Step 2: In silico simulations and analysis.
Once the cell/condition specific model has been gener-
ated, it can be used to study blood cell storage lesions.
In silico simulations by the use of constraint-based
modeling [28] can unravel mechanisms and interac-
tions of cellular networks involved in the development
of blood cell storage lesions. There are a plethora of
methods that have been developed and will likely
continue to be developed that enable in silico analysis
[29]. Subsequently, constraint-based modeling can be
used to drive experimental hypothesis for extending
the expiration date.
iii. Step 3: Experimental validation.
Experimental validation involves a dynamic process
referring back to iterative revisions to the model. In
silico generated hypotheses are tested and compared
with experimental results. In case of erroneous pre-
dictions, revision of the model is required and new
hypotheses are generated. The number of iterations
and rounds of hypothesis testing is not fixed, and can in
principle be continued indefinitely, producing more
nuanced and detailed levels of understanding of un-
derlying biochemical mechanisms through evaluation
of multiple hypotheses.
The use of systems biology and integrated omics repre-
sents a concrete solution in the study of blood cell storage
lesions, and it may open up new avenues towards developing
better storage methods and better storage media, thereby
extending the storage period of blood components. This is
crucial to overcome the increasing deficit in the supply and
rising demand of blood components in the future.
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